Araştırma Makalesi
BibTex RIS Kaynak Göster

Kolorektal Kanserde Tiyol–Disülfit Düzeyleri

Yıl 2019, , 137 - 141, 13.06.2019
https://doi.org/10.21673/anadoluklin.469201

Öz

Amaç: Bu çalışmada kolorektal kanserli hastalarda natif tiyol, disülfit
ve total tiyol konsantrasyonları ile CEA ve CA-19-9 serum biyobelirteçlerini değerlendirmek
ve sonuçları sağlıklı bireylerle karşılaştırmak amaçlanmıştır.

Gereç ve Yöntemler: Çalışmaya 23 kolorektal kanserli hasta ve 23 sağlıklı
birey olmak üzere toplam 46 kişi dahil edildi. Tiyol/disülfit homeostaz
testleri (natif tiyol [-SH], disülfit [-S-S] ve total tiyol [TT]) yeni bir
otomatize metotla gerçekleştirildi. İskemi modifiye albümin (IMA), albümin,
karsinoembriyojenik antijen (CEA), karbonhidrat antijen 19-9 (CA-19-9), TT, -SH
ve -S-S seviyeleri ile disülfit/natif tiyol ve disülfit/total tiyol oranları
gruplar arasında karşılaştırıldı.

Bulgular: Kolorektal kanserli grupta IMA, CEA ve CA-19-9’da kontrol
grubuna kıyasla istatistiksel ola­rak anlamlı farklılık bulundu (p<0,05).
Kontrol grubunda tiyol–disülfit parametreleri ve tümör biyobelir­teçleri arasında
bir ilişki saptanmadı (p>0,05). Kolorektal kanserli hastalarda tiyol–disülfit
parametre­leri ile IMA, albümin, CEA ve CA-19-9 düzeyleri arasında bir ilişki
saptanmadı (p>0,05).







Tartışma ve Sonuç: Çalışmamız noninvaziv bir biyobelirteç olarak natif
tiyol (-SH), disülfit (-S-S) ve total tiyol (TT) konsantrasyonları ile
kolorektal kanser arasında bir ilişki olmadığını göstermektedir.

Kaynakça

  • Referans1.Valko M, Rhodes CJ, Moncola J, et al. Free radicals, metals and antioxidants in oxidativestress-induced cancer.Chemico-Biological Interactions 160 ; 2006: 1–40.
  • Referans2. Özgönül A, Aksoy N, Dilmeç F, et al. Measurement of total antioxidant response in colorectal cancer using a novel automated method.Turk J Med Sci. 2009; 39 (4): 503-506.
  • Referans3. Türkiye İstatistik Kurumu, Ölüm Nedeni İstatistikleri, Haber Bülteni, 2017; Sayı: 27620. http://www.tuik.gov.tr/PreHaberBultenleri.do?id=27620
  • Referans4. Tatar M, Tatar F. “Colorectal cancer in Turkey: current situation and challenges for the future” Eur J Health Econ . 2010; 10 (Suppl 1):99–105.
  • Referans5. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study- The lancet oncology,13( 8): 790-801, 2012.
  • Referans6. Siegel RL, Miller KD, Jemal A. Cancer statistics, CA: A Cancer Journal for Clinicians 2017;67(1): 7-30.
  • Referans7. Özdemir A, Erel O. Thıol-Dısulfide Balance : Could be a new marker for Thyroid Cancer? Journal of Cancer Therapy (JCT). 2018; 9 (8).
  • Referans8. Skrzydlewska E, Sulkowski S,Koda M, Zalewski B, et al. Lipid peroxidation and antioxidant status in colorectal cancer. World Journal of Gastroenterology 2005;11(3):403-406.
  • Referans9. Skrzydlewska E, Kozuszko B, Sulkowska M, et al. Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology 2003; 50(49): 126-31.
  • Referans10. Li F, Yang XW, Krausz KW, Nichols RG, et al. Modulation of Colon Cancer. Nutmeg J. Proteome Res. 2015;14: 1937−1946.
  • Referans11. Sedef Hande Enfez. Kemoterapinin Kolon-Kanseri Ve Meme-KanserindeVEGF Yüzeylerinde İnvivo Ve İnvitro İncelenmesi, Yüksek Lisans Tezi, Ankara Üniversitesi Biyoteknoloji Enstitüsü, 2010.
  • Referans12. Giustarini D, Dalle-Donne I, Lorenzini S, et al. Age-Related Influence on Thiol, Disulfide, and Protein-Mixed Disulfide Levels in Human Plasma.The Journals of Gerontology: Series A,61(10): 1030–1038, 2016. Referans13. BelenichevIF, Gorbacheva SV, Demchenko AV. Et al. The thiol-disulfide balance and the nitric oxide system in the brain tissue of rats subjected to experimental acute impairment of cerebral blood flow: The therapeutic effects of nootropic drugs. Neurochemical Journal, 2014; 8( 1): 24–27.
  • Referans14. Sedlak J, Lindsay RH. Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25(1): 192-205.
  • Referans15. Davies MJ, Fu S, Wang H, et al. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med 1999; 27(11-12): 1151-63.
  • Referans16. Cerutti PA. 1985, Prooxidant states and tumor promotion. Science; 227:375-81.
  • Referans17. Link A, Balaguer F, Shen Y, et al. Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening. Cancer Epidemiol Biomarkers Prev; 19(7) July 2010.
  • Referans18. Ogata-Kawata H, Izumiya M, Kurioka D. et al. Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. 2014:9 (4): e92921.
  • Referans19. Erel, O. and Neselioglu, SA. Novel and Automated Assay for Thiol/Disulfide Homeostasis. Clinical Biochemistry 2014; 47, 326-332. Referans20. Chianeh,YR., Prabhu,K. 2014, Protein Thiols as an Indicator of Oxidative Stress Oksidatif, Archives Medical Review Journal. 2014; 23(3): 443-456.Referans21. Dirican N, Dirican A, Şen O, Aynalı A, et al. Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Report 2016; 21(5).
  • Referans22. Hizal M, Sendur MAN, Bilgin B. et al. Evaluation of dynamic serum thiol/disulfide homeostasis in locally advanced and metastatic gastric cancer. Journal of Oncological Sciences 4(2018) 1-4.

The Level of Thiol-Disulfide on Colorectal Cancer

Yıl 2019, , 137 - 141, 13.06.2019
https://doi.org/10.21673/anadoluklin.469201

Öz

Aim: This study aimed to evaluate total thiol (TT), disulfide (-S-S),
and native thiol (-SH) concentra­tions as serum biomarkers in patients with
colorectal cancer (CRC).

Materials and Methods: A total of 46 participants (23 patients with
colorectal cancer and 23 healthy individuals) were included. Thiol/disulfide
homeostasis tests (total thiol [TT], native thiol [-SH], and di­sulfide [-S-S])
were performed by a novel automated method. Ischemia modified albumin (IMA),
albu­min, carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA-19-9),
TT, -SH, and -S-S levels as well as disulfide/native thiol and disulfide/total
thiol ratios were compared between the groups.

Results: In the colorectal cancer group, statistically significant difference
was found in IMA, CEA, and CA-19-9, compared to the control group (p<0.05).
There was no relationship between the thiol–disul­fide parameters and tumor
markers in the control group (p>0.05). There was no relationship between the
thiol–disulfide parameters and IMA, albumin, CEA, and CA-19-9 levels in the
colorectal cancer group (p>0.05).







Discussion and Conclusion: Our study shows that the serum concentrations
of native -SH, -S-S, and TT do not link to colorectal cancer as a noninvasive
biomarker.

Kaynakça

  • Referans1.Valko M, Rhodes CJ, Moncola J, et al. Free radicals, metals and antioxidants in oxidativestress-induced cancer.Chemico-Biological Interactions 160 ; 2006: 1–40.
  • Referans2. Özgönül A, Aksoy N, Dilmeç F, et al. Measurement of total antioxidant response in colorectal cancer using a novel automated method.Turk J Med Sci. 2009; 39 (4): 503-506.
  • Referans3. Türkiye İstatistik Kurumu, Ölüm Nedeni İstatistikleri, Haber Bülteni, 2017; Sayı: 27620. http://www.tuik.gov.tr/PreHaberBultenleri.do?id=27620
  • Referans4. Tatar M, Tatar F. “Colorectal cancer in Turkey: current situation and challenges for the future” Eur J Health Econ . 2010; 10 (Suppl 1):99–105.
  • Referans5. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study- The lancet oncology,13( 8): 790-801, 2012.
  • Referans6. Siegel RL, Miller KD, Jemal A. Cancer statistics, CA: A Cancer Journal for Clinicians 2017;67(1): 7-30.
  • Referans7. Özdemir A, Erel O. Thıol-Dısulfide Balance : Could be a new marker for Thyroid Cancer? Journal of Cancer Therapy (JCT). 2018; 9 (8).
  • Referans8. Skrzydlewska E, Sulkowski S,Koda M, Zalewski B, et al. Lipid peroxidation and antioxidant status in colorectal cancer. World Journal of Gastroenterology 2005;11(3):403-406.
  • Referans9. Skrzydlewska E, Kozuszko B, Sulkowska M, et al. Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology 2003; 50(49): 126-31.
  • Referans10. Li F, Yang XW, Krausz KW, Nichols RG, et al. Modulation of Colon Cancer. Nutmeg J. Proteome Res. 2015;14: 1937−1946.
  • Referans11. Sedef Hande Enfez. Kemoterapinin Kolon-Kanseri Ve Meme-KanserindeVEGF Yüzeylerinde İnvivo Ve İnvitro İncelenmesi, Yüksek Lisans Tezi, Ankara Üniversitesi Biyoteknoloji Enstitüsü, 2010.
  • Referans12. Giustarini D, Dalle-Donne I, Lorenzini S, et al. Age-Related Influence on Thiol, Disulfide, and Protein-Mixed Disulfide Levels in Human Plasma.The Journals of Gerontology: Series A,61(10): 1030–1038, 2016. Referans13. BelenichevIF, Gorbacheva SV, Demchenko AV. Et al. The thiol-disulfide balance and the nitric oxide system in the brain tissue of rats subjected to experimental acute impairment of cerebral blood flow: The therapeutic effects of nootropic drugs. Neurochemical Journal, 2014; 8( 1): 24–27.
  • Referans14. Sedlak J, Lindsay RH. Estimation of total, proteinbound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25(1): 192-205.
  • Referans15. Davies MJ, Fu S, Wang H, et al. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med 1999; 27(11-12): 1151-63.
  • Referans16. Cerutti PA. 1985, Prooxidant states and tumor promotion. Science; 227:375-81.
  • Referans17. Link A, Balaguer F, Shen Y, et al. Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening. Cancer Epidemiol Biomarkers Prev; 19(7) July 2010.
  • Referans18. Ogata-Kawata H, Izumiya M, Kurioka D. et al. Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. 2014:9 (4): e92921.
  • Referans19. Erel, O. and Neselioglu, SA. Novel and Automated Assay for Thiol/Disulfide Homeostasis. Clinical Biochemistry 2014; 47, 326-332. Referans20. Chianeh,YR., Prabhu,K. 2014, Protein Thiols as an Indicator of Oxidative Stress Oksidatif, Archives Medical Review Journal. 2014; 23(3): 443-456.Referans21. Dirican N, Dirican A, Şen O, Aynalı A, et al. Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Report 2016; 21(5).
  • Referans22. Hizal M, Sendur MAN, Bilgin B. et al. Evaluation of dynamic serum thiol/disulfide homeostasis in locally advanced and metastatic gastric cancer. Journal of Oncological Sciences 4(2018) 1-4.
Toplam 19 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm ORJİNAL MAKALE
Yazarlar

Ayşe Özdemir 0000-0003-2639-7344

Utku Dönem Dilli Bu kişi benim

Dalyan Özdemir Bu kişi benim 0000-0003-2639-7344

Salim Neşelioğlu

Özcan Erel

Yayımlanma Tarihi 13 Haziran 2019
Kabul Tarihi 11 Ocak 2019
Yayımlandığı Sayı Yıl 2019

Kaynak Göster

Vancouver Özdemir A, Dilli UD, Özdemir D, Neşelioğlu S, Erel Ö. The Level of Thiol-Disulfide on Colorectal Cancer. Anadolu Klin. 2019;24(2):137-41.

13151 This Journal licensed under a CC BY-NC (Creative Commons Attribution-NonCommercial 4.0) International License.